Genetic polymorphism of the iron-regulatory protein-1 and -2 genes in age-related macular degeneration

Molecular Biology Reports

Volumn 39, Issue 6, 2012, Pages 7077-7087

  Synowiec, Ewelina ^a   Pogorzelska, Magdalena ^a   Blasiak, Janusz ^a,b   Szaflik, Jerzy ^b   Szaflik, Jacek Pawel ^b  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Age related macular degeneration; AMD; Gene polymorphism; Iron; Iron regulatory proteins; IRP 1 and 2; Oxidative stress; Reactive oxygen species

Indexed keywords

IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; OLIGONUCLEOTIDE;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPING TECHNIQUE; HUMAN; HUMAN CELL; IRON METABOLISM; IRON REGULATORY PROTEIN 1 GENE; IRON REGULATORY PROTEIN 2 GENE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

5' FLANKING REGION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; LOGISTIC MODELS; MACULAR DEGENERATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; RNA STABILITY; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC;

EID: 84864287708     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1539-6     Document Type: Article

References (63)

1. Meyer KJ, Davis LK, Schindler EI, Beck JS, Rudd DS, Grundstad AJ, Scheetz TE, Braun TA, Fingert JH, Alward WL, Kwon YH, Folk JC, Russell SR, Wassink TH, Stone EM, Sheffield VC (2010) Genome-wide analysis of copy number variants in age-related macular degeneration. Hum Genet 129:91-100
2. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd (2005) Age-related eye disease study research group. Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS) AREDS report no. 19. Ophthalmology 112:533-539 (Pubitemid 41108849)
3. World Health Organization (WHO). Priority eye diseases.http://www.who. int/blindness/causes/priority/en/index8.html. Accessed October 2009
4. Gehrs KM, Anderson DH, Johnson LV, Hageman GS (2006) Age-related macular degeneration emerging pathogenetic and therapeutic concepts. Ann Med 38:450-471 (Pubitemid 44767496)
5. National Eye Institute, US National Institutes of Health. Facts about age-related macular degeneration. http://www.nei.nih.gov/health/maculardegen/ armd-facts.asp. Accessed August 2010
6. Coleman HR, Chan CC, Ferris FL 3rd, Chew EY (2008) Age-related macular degeneration. Lancet 372:1835-1845
7. Jager RD, Mieler WF, Miller JW (2008) Age-related macular degeneration. N Engl J Med 358:2606-2617
8. Weiter JJ, Delori FC, Wing GL, Fitch KA (1986) Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci 27:145-152 (Pubitemid 16129780)
9. Kawasaki R, Wang JJ, Ji GJ, Taylor B, Oizumi T, Daimon M, Kato T, Kawata S, Kayama T, Tano Y, Mitchell P, Yamashita H, Wong TY (2008) Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Fun-agata study. Ophthalmology 115:1376-1381
10. Ayala-Haedo JA, Gallins PJ, Whitehead PL, Schwartz SG, Kov-ach JL, Postel EA, Agarwal A, Wang G, Haines JL, Pericak-Vance MA, Scott WK (2010) Analysis of single nucleotide polymorphisms in the NOS2A gene and interaction with smoking in age-related macular degeneration. Ann Hum Genet 74:195-201
11. McCall MR, Frei B (1999) Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med 26: 1034-1053 (Pubitemid 29198377)
12. Ohia SE, Opere CA, Leday AM (2005) Pharmacological consequences of oxidative stress in ocular tissues. Mutat Res 579: 22-36 (Pubitemid 41540130)
13. Khandhadia S, Lotery A (2010) Oxidation and age-related mac-ular degeneration: insights from molecular biology. Expert Rev Mol Med 12:e34
14. Totan Y, Yaǧci R, Bardak Y, Ozyurt H, Kendir F, Yilmaz G, Sahin S, Sahin Tiǧ U (2009) Oxidative macromolecular damage in age-related macular degeneration. Curr Eye Res 34:1089-1093
15. Wong RW, Richa DC, Hahn P, Green WR, Dunaief JL (2007) Iron toxicity as a potential factor in AMD. Retina 27:997-1003 (Pubitemid 350303998)
16. Blasiak J, Szaflik J, Szaflik JP (2011) Implications of altered iron homeostasis for age-related macular degeneration. Front Biosci 16:1551-1559
17. Hahn P, Ying GS, Beard J, Dunaief JL (2006) Iron levels in human retina: sex difference and increase with age. Neuroreport 17:1803-1806 (Pubitemid 44948111)
18. Smith W, Mitchell P (1998) Family history and age-related maculopathy: the blue mountains eye study. Aust N Z J Oph-thalmol 26:203-206 (Pubitemid 28372494)
19. Hyman L, Neborsky R (2002) Risk factors for age-related mac-ular degeneration: an update. Curr Opin Ophthalmol 13:171-175 (Pubitemid 34518202)
20. Scholl HP, Fleckenstein M, Charbel IP, Keilhauer C, Holz FG, Weber BH (2007) An update on the genetics of age-related macular degeneration. Mol Vis 13:196-205 (Pubitemid 46232110)
21. Seddon JM, Cote J, Page WF, Aggen SH, Neale MC (2005) The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123: 321-327 (Pubitemid 41007575)
22. Klaver CC, Wolfs RC, Assink JJ, van Duijn CM, Hofman A, de Jong PT (1998) Genetic risk of age-related maculopathy population-based familial aggregation study. Arch Ophthalmol 116: 1646-1651 (Pubitemid 29001964)
23. Seddon JM, Francis PJ, George S, Schultz DW, Rosner B, Klein ML (2007) Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 297:1793-1800 (Pubitemid 46658648)
24. Ting AY, Lee TK, MacDonald IM (2009) Genetics of age-related macular degeneration. Curr Opin Ophthalmol 20:369-376
25. Luo L, Harmon J, Yang X, Chen H, Patel S, Mineau G, Yang Z, Constantine R, Buehler J, Kaminoh Y, Ma X, Wong TY, Zhang M, Zhang K (2008) Familial aggregation of age-related macular degeneration in the Utah population. Vis Res 48:494-500 (Pubitemid 351179527)
26. Janik-Papis K, Zaras M, Krzyzanowska A, Wozniak K, Blasiak J, Szaflik J, Szaflik JP (2009) Association between vascular endo-thelial growth factor gene polymorphisms and age-related mac-ular degeneration in a Polish population. Exp Mol Pathol 87(3):234-238
27. Fuse N, Mengkegale M, Miyazawa A, Abe T, Nakazawa T, Wakusawa R, Nishida K (2011) Polymorphisms in ARMS2 (LOC387715) and LOXL1 genes in the Japanese with age-related macular degeneration. Am J Ophthalmol 151:550-556
28. Güven M, Görgün E, Unal M, Yenerel M, Batar B, Küçümen B, Dinç UA, Güven GS, Ulus T, Yüksel A (2011) Glutathione S-transferase M1, GSTT1 and GSTP1 genetic polymorphisms and the risk of age-related macular degeneration. Ophthalmic Res 46:31-37
29. Langaee T, Shin J (2010) The genetics basis of pharmatoge-nomics. In: Zdanowicz MM (ed) Concepts in pharmacogenomics. American Society of Health-System Pharmacists, Bethesda, p 29
30. Geirsdottir A, Stefansson E, Jonasson F, Helgadottir G, Sig-urdsson H (2007) Age-related macular degeneration in very old individuals with family history. Am J Ophthalmol 143:889-890 (Pubitemid 46601367)
31. Ting AY, Lee TK, MacDonald IM (2009) Genetics of age-related macular degeneration. Curr Opin Ophthalmol 20:369-376
32. Vingerling JR, Hofman A, Grobbee DE, de Jong PT (1996) Age-related macular degeneration and smoking. The Rotterdam study. Arch Ophthalmol 114:1193-1196 (Pubitemid 26338849)
33. Khan JC, Thurlby DA, Shahid H, Clayton DG, Yates JR, Bradley M, Moore AT, Bird AC, Genetic factors in AMD study (2006) Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol 90:75-80 (Pubitemid 43029901)
34. Dunaief JL (2006) Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan lecture. Invest Ophthalmol Vis Sci 47:4660-4664 (Pubitemid 46586359)
35. Beatty S, Koh H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115-134
36. Shen J, Yang X, Dong A, Petters RM, Peng YW, Wong F, Campochiaro PA (2005) Oxidative damage is a potential cause of cone cell death in retinitis pigmentosa. J Cell Physiol 203:457-464 (Pubitemid 40629006)
37. Wu Z, Lauer TW, Sick A, Hackett SF, Campochiaro PA (2007) Oxidative stress modulates complement factor H expression in retinal pigmented epithelial cells by acetylation of FOXO3. J Biol Chem 282:22414-22425 (Pubitemid 47267308)
38. Age-related eye disease study research group (AREDS) (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 119:1439-1452
39. Farkas RH, Chowers I, Hackam AS, Kageyama M, Nickells RW, Otteson DC, Duh EJ, Wang C, Valenta DF, Gunatilaka TL, Pease ME, Quigley HA, Zack DJ (2004) Increased expression of iron-regulating genes in monkey and human glaucoma. Invest Oph-thalmol Vis Sci 45:1410-1417 (Pubitemid 38859319)
40. Moos T, Morgan EH (2004) The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann N Y Acad Sci 1012:14-26 (Pubitemid 38453512)
41. Hahn P, Milam AH, Dunaief JL (2003) Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane. Arch Ophthalmol 12:1099-1105 (Pubitemid 36962162)
42. Hahn P, Qian Y, Dentchev T, Chen L, Beard J, Harris ZL, Dunaief JL (2004) Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci USA 10138:13850-13855 (Pubitemid 39298496)
43. Muckenthaler MU, Galy B, Hentze MW (2008) Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr 28: 197-213
44. Volz K (2008) The functional duality of iron regulatory protein 1. Curr Opin Struct Biol 18:106-111
45. Viatte L, Gröne HJ, Hentze MW, Galy B (2009) In vivo role(s) of the iron regulatory proteins (IRP) 1 and 2 in aseptic local inflammation. J Mol Med (Berl) 87:913-921
46. Hahn P, Dentchev T, Qian Y, Rouault T, Harris ZL, Dunaief JL (2004) Immunolocalization and regulation of iron handling proteins ferritin and ferroportin in the retina. Mol Vis 10:598-607 (Pubitemid 41358237)
47. Smith SR, Ghosh MC, Ollivierre-Wilson H, Hang Tong W, Rouault TA (2006) Complete loss of iron regulatory proteins 1 and 2 prevents viability of murine zygotes beyond the blastocyst stage of embryonic development. Blood Cells Mol Dis 36:283-287
48. Galy B, Ferring-Appel D, Kaden S, Gröne HJ, Hentze MW (2008) Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum. Cell Metab 7:79-85
49. Hentze MW, Kühn LC (1996) Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 93:8175-8182 (Pubitemid 26269529)
50. Rouault TA (2006) The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2: 406-414 (Pubitemid 44114917)
51. Goforth JB, Anderson SA, Nizzi CP, Eisenstein RS (2010) Multiple determinants within iron-responsive elements dictate iron regulatory protein binding and regulatory hierarchy. RNA 16:154-169
52. Lakhanpal V, Schocket SS, Jiji R (1984) Deferoxamine (desfer-al)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy. Ophthalmology 91:443-451 (Pubitemid 14149071)
53. Doly M, Bonhomme B, Vennat JC (1986) Experimental study of the retinal toxicity of hemoglobinic iron. Ophthalmic Res 18: 21-27 (Pubitemid 16170338)
54. Wang ZJ, Lam KW, Lam TT, Tso MO (1998) Iron-induced apoptosis in the photoreceptor cells of rats. Invest Ophthalmol Vis Sci 39:631-633 (Pubitemid 28110697)
55. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308:419-421 (Pubitemid 40530081)
56. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385-389 (Pubitemid 40530070)
57. Kanda A, Chen W, Othman M, Branham KE, Brooks M, Khanna R, He S, Lyons R, Abecasis GR, Swaroop A (2007) A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci USA 104:16227-16232 (Pubitemid 350099389)
58. Montezuma SR, Sobrin L, Seddon JM (2007) Review of genetics in age related macular degeneration. Semin Ophthalmol 22:229-240
59. Fritsche LG, Loenhardt T, Janssen A, Fisher SA, Rivera A, Keilhauer CN, Weber BH (2008) Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet 40:892-896 (Pubitemid 351913654)
60. Patel N, Adewoyin T, Chong NV (2008) Age-related macular degeneration: a perspective on genetic studies. Eye 22(6):768-776 (Pubitemid 351850512)
61. Ding X, Patel M, Chan CC (2009) Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 28:1-18
62. Hentze MW, Muckenthaler MU, Andrews NC (2004) Balancing acts: molecular control of mammalian iron metabolism. Cell 117:285-297 (Pubitemid 38534536)
63. Madsen E, Gitlin JD (2007) Copper and iron disorders of the brain. Annu Rev Neurosci 30:317-337 (Pubitemid 47224759)